PharmaCielo (PCLOF) News

Latest news and analysis

PharmaCielo Plummets 26.4% as CBD Stock Hits Multi-Month Lows

PharmaCielo shares crashed to $0.04 amid increased selling pressure, with the Colombian CBD company now trading near 52-week lows.

1d agoCannabismarketcap

PharmaCielo Crashes 26.4% as CBD Company Hits New Lows

PharmaCielo plummeted to $0.04 per share amid continued struggles in the CBD market, trading near 52-week lows with elevated volume.

3d agoCannabismarketcap

PharmaCielo Crashes 26.4% as CBD Stock Hits New Lows

PharmaCielo plummeted 26.4% to $0.04, bringing its market cap to just $7.4M as the CBD company continues its steep decline from 52-week highs.

4d agoCannabismarketcap

PharmaCielo Crashes 26.4% as CBD Stock Hits Near 52-Week Low

PCLOF plummeted to $0.04 on elevated volume of 30,126 shares, bringing market cap down to $7.4M amid ongoing sector headwinds.

5d agoCannabismarketcap

PharmaCielo Plummets 26.4% as CBD Stock Hits Critical Support

PharmaCielo shares crashed to $0.04 on elevated volume, marking a new low for the struggling CBD company.

6d agoCannabismarketcap

PharmaCielo Plummets 26.4% as CBD Stock Hits Near 52-Week Low

PharmaCielo shares crashed to $0.04 amid heavy selling pressure, bringing the Colombian cannabis company's market cap to just $7.4 million.

Jun 21, 2026Cannabismarketcap

PharmaCielo Crashes 26.4% to Four-Cent Territory on Heavy Volume

Cannabis company PharmaCielo plummeted over a quarter of its value in a single session, hitting new lows amid increased trading activity.

Jun 19, 2026Cannabismarketcap

PharmaCielo Shares Crater 26.4% as Cannabis Stock Hits New Lows

PharmaCielo plummeted to $0.04 per share amid heavy selling pressure, bringing the Colombian cannabis company's market cap down to just $7.4 million.

Jun 18, 2026Cannabismarketcap

PharmaCielo Crashes 26.4% as CBD Stock Hits Near 52-Week Lows

PharmaCielo shares plummeted to $0.04 amid elevated trading volume, bringing the company's market cap down to just $7.4 million.

Jun 16, 2026Cannabismarketcap

PharmaCielo Crashes 26% as CBD Stock Hits New Lows

PharmaCielo shares plummeted 26.4% to $0.04, marking another significant decline for the struggling CBD company as volume surged.

Jun 15, 2026Cannabismarketcap

PharmaCielo Crashes 26.4% to Near-Zero Levels on Heavy Volume

PCLOF shares plummeted to $0.04 as the Colombian cannabis company faces mounting financial pressures amid sector-wide challenges.

Jun 12, 2026Cannabismarketcap

Frequently Asked Questions

Where can I find reliable news about PharmaCielo (PCLOF)?+
Cannabismarketcap aggregates news from over 20 trusted cannabis industry sources including Marijuana Moment, MJBizDaily, New Cannabis Ventures, and major financial outlets. For PCLOF specifically, you can follow this page for curated news, check the company's SEC filings for official announcements, and monitor press releases on their investor relations page. Industry-specific sources tend to provide more detailed cannabis coverage than general financial media.
How does news affect PCLOF's stock price?+
News can significantly impact PharmaCielo's stock price, especially in the cannabis sector where stocks tend to be more volatile. Regulatory news (federal legalization updates, state license approvals, DEA rescheduling) typically has the biggest impact across the entire sector. Company-specific news like earnings reports, acquisition announcements, executive changes, and new market entries directly affect PCLOF. Cannabis stocks can move 5-20% on significant news due to lower liquidity and high retail investor participation.
What news sources cover the cannabis industry?+
Major cannabis-specific news outlets include Marijuana Moment (policy and politics), MJBizDaily (business and industry), New Cannabis Ventures (public company focus), Leafly (consumer and science), High Times (culture and business), and Cannabis Wire (investigative journalism). Financial coverage comes from Benzinga Cannabis, Motley Fool, Yahoo Finance, and Seeking Alpha. International sources include Prohibition Partners, StratCann (Canada), and Mugglehead. Each source has different strengths and editorial perspectives.
How should I evaluate cannabis news for investing in PCLOF?+
When reading cannabis news, consider the source's credibility, whether claims are backed by official filings or named sources, and the potential timeline for any regulatory changes. Distinguish between confirmed developments (SEC filings, signed legislation) and speculation (rumored M&A, proposed bills). For PharmaCielo, focus on news that directly affects its operations: state market developments where it operates, regulatory changes affecting its license type, and competitive dynamics in its key markets.
What types of news have the most impact on cannabis stocks like PCLOF?+
The most impactful news categories for cannabis stocks are: (1) Federal regulatory changes like rescheduling, SAFE Banking, or legalization bills, which can move the entire sector 10-30%; (2) Earnings reports and guidance updates; (3) M&A announcements; (4) State-level regulatory decisions (new licenses, market openings); (5) FDA or Health Canada decisions on specific products; and (6) Major institutional investor activity. For PCLOF specifically, news about its operating markets and competitive position tends to have the most direct impact.
How often is PCLOF news updated on Cannabismarketcap?+
Cannabismarketcap updates cannabis news continuously throughout the day, with new articles published as developments occur. Our news feed aggregates from 20+ sources and covers both company-specific news and broader industry developments. For PharmaCielo, articles are automatically tagged when they mention PCLOF, so this page always shows the most recent coverage. Check back regularly or visit our main news page for comprehensive industry coverage.

More on PCLOF